Literature DB >> 14769869

Expression, purification, and characterization of humanized anti-HBs Fab fragment.

Deng Ning1, Xiang Junjian, Wang Xunzhang, Chen Wenyin, Zhang Qing, Su Kuanyuan, Rao Guirong, Ren Xiangrong, Long Qingxin, Yu Zhouyao.   

Abstract

Anti-HBs Fab fragment has considerable potential for use in the prevention and treatment of liver diseases by HBV. Here we established a high-level expression system to directly produce anti-HBs Fab fragment in Pichia pastoris. This was achieved by co-integration of the genes encoding the heavy and light chains both under the genome of the yeast cells. The Fab fragment was efficiently secreted into medium at a concentration of 50 mg/liter. The authenticity of the Fab fragment was confirmed by immunoblot analysis, which yielded one band of approximately 50 kDa under nonreducing conditions and two bands of approximately 28 kDa under reducing conditions. The anti-HBs Fab fragment was prepared with a purity of 95% by affinity chromatography. The affinity activity of the recombinant Fab was detected by ELISA, which indicated that 1 mg of recombinant Fab was equivalent to 40 IU HBIG (20 IU/mg). The results demonstrated that the recombinant Fab fragment could sufficiently neutralize the HBsAg.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769869     DOI: 10.1093/jb/mvg204

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice.

Authors:  Ran Zhang; Dan Cui; Hong Wang; Chuan Li; Xin Yao; Yaofeng Zhao; Mifang Liang; Ning Li
Journal:  Transgenic Res       Date:  2012-10       Impact factor: 2.788

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

3.  Bioprocess development for extracellular production of recombinant human interleukin-3 (hIL-3) in Pichia pastoris.

Authors:  Vikas Kumar Dagar; Nirmala Devi; Yogender Pal Khasa
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-11       Impact factor: 3.346

4.  Construction of a disulfide-stabilized diabody against fibroblast growth factor-2 and the inhibition activity in targeting breast cancer.

Authors:  Yaxiong Cai; Jinxia Zhang; Xuejun Lao; Haowu Jiang; Yunfei Yu; Yanrui Deng; Jiangchuan Zhong; Yiye Liang; Likuan Xiong; Ning Deng
Journal:  Cancer Sci       Date:  2016-07-26       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.